Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Argos Therapeutics Inc.

TRADE

NASDAQ: ARGSHealthcare / Biotechnology / USA
0.158+0.013+8.82%Vol 28 1021Y Perf -97.57%
Jul 20th, 2018 15:40
BID0.00 ASK0.00
Open0.143 Previous Close0.145
Pre-Market- After-Trading-
 - -%  - -%
Target Price
0.75 
Analyst Rating
— 0.00
Potencial %
374.98 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/-100 
Income Ranking
 —    -
Market Cap (mil)1 
Earnings Rating
Buy
Price Range Ratio 52wk %
0.22 
Earnings Date
8th Aug 2018

Today's Price Range

0.140.17

 

52wk Range

0.1389.40

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-9.77%
3 Months
-45.55%
6 Months
-92.72%
1 Year
-97.57%
3 Years
-97.43%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ARGS0.1580.01288.82
AAPL191.44-0.4400-0.23
GOOG1 184.91-2.0500-0.17
MSFT106.271.87001.79
XOM81.40-0.6100-0.74
WFC56.410.08000.14
JNJ125.85-0.0900-0.07
FB209.941.85000.89
GE13.12-0.6100-4.44
JPM111.281.39001.26
...

TickerPriceChg.%52 Week High
CTAS203.575.11204.27
PM84.314.22120.00
VFC92.944.1593.51
HON153.133.79165.13
SWK144.233.28176.62
PDCO23.642.8743.20
DOV80.242.7188.11
STI70.842.6473.37
ADS233.082.59278.33
NUE66.252.4470.48
KSU111.052.40114.91
IDXX248.142.19248.65
COF97.231.95106.50
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 1.60
Current Ratio 1.70
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -24.50
Leverage Ratio -3.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-231.40
EBITDA Margin-219.20
Pre-tax Profit Margin-5 083.00
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 2.88
PS Ratios 0.24
Price to Cash Flow -
Price to Free Cash Flow -0.10
Cash Flow Per Share -6.01
Price to Tangible Book-0.57
Book Value per Share-0.30
Enterprise Value (in ths.)3 914
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)281.12
ROE last 12 Months 194.69
Return on Assets (5Y Avg) -193.56
ROA last 12 Months -65.64
Return on Capital (5Y Avg) -
ROC last 12 Months -186.76
Return on invested Capital Q -
Return on invested Capital Y-32.59
Assets Turnover0.10
Receivables Turnover25.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)7 657
Revenue per Share 0.72
Revenue Growth 3 Years 52.90
Revenue Growth 5 Years -23.33
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q04 2017--1.05-
Q03 2017--0.10-
Q02 2017-0.13-0.21-61.54
Q01 2017--0.58-
Q03 2016-0.32-0.320.00
Q02 2016-0.40-0.48-20.00
Q01 2016-0.56-0.57-1.79
Q04 2015-0.86-0.842.33
Earnings Per EndEstimateRevision %Trend
9/2017 QR-0.15-7.14Negative
12/2017 QR-0.150.00-
12/2017 FY-1.08-22.73Negative
12/2018 FY-0.48-9.09Negative
Next Report Date8th Aug 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume28 102
Shares Outstanding (in ths.)7 910
Trades Count15
Dollar Volume3 961
Avg. Volume550 252
Avg. Weekly Volume35 396
Avg. Monthly Volume36 204
Avg. Quarterly Volume139 925

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

59%41%

Bearish Bullish

65%35%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0 (0.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
1 (100.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Rating--Hold
3.00

There are no comments yet.

News

x